Despite the substantial over-expression of both ATF3 and HDAC2 after brain ischemia, only the increase in ATF3 and BCL11B co-expression was observed, while BCL11B and HDAC2 co-expression was not altered, indicating increase of BCL11B was associated with the beneficial processes after brain ischemia. The gene discussed is ATF3; the disease is brain ischemia.